STRO logo

STRO

Sutro Biopharma Inc.

$0.89
+$0.00(+0.39%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$75.58M
Volume
187.37K
52W Range
$0.52 - $4.60
Target Price
$2.69
Order:

Income Statement

MetricTrendChart
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$38.4M$42.7M$42.7M$61.9M$67.8M$153.7M$62.0M
Total Revenue
$38.4M$42.7M$42.7M$61.9M$67.8M$153.7M$62.0M
GROSS PROFIT
Gross Profit
$38.4M$42.7M$42.7M$61.9M$67.8M$153.7M$62.0M
OPERATING EXPENSES
Operating Expenses
$-75.6M$98.2M$113.8M$160.4M$196.7M$243.0M$300.5M
Research & Development
$54.3M$65.6M$77.0M$104.4M$137.2M$180.4M$252.0M
Research Expense
$54.3M$65.6M$77.0M$104.4M$137.2M$180.4M$252.0M
Selling, General & Administrative
$21.4M$32.6M$36.8M$56.0M$59.5M$62.6M$48.5M
General & Administrative Expenses
$21.4M$32.6M$36.8M$56.0M$59.5M$62.6M$48.5M
Salaries & Wages
$-2.9M------$26.3M$24.9M$24.7M
Depreciation & Amortization
----$4.3M$4.8M$5.7M$6.8M$7.2M
Depreciation & Amortization
----$4.3M$4.8M$5.7M$6.8M$7.2M
Amortization
--$200.0K$500.0K$600.0K$500.0K$300.0K--
Other Operating Expenses
$-741.0K$-1.0M$-1.1M$-1.5M$-2.3M$-2.6M$-3.5M
OPERATING INCOME
Operating income
$-37.2M$-55.5M$-71.1M$-98.5M$-128.9M$-89.3M$-238.5M
EBITDA
$-33.2M$-47.0M$-23.8M$-97.6M$-107.7M$-81.8M$-217.9M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$-1.6M$1.1M$4.0M$3.1M$3.3M$23.8M--
Net Non-Operating Interest Income/Expense
$1.6M$-1.1M$-2.3M$-2.6M$-109.0K$9.2M--
Gain on Sale of Securities
$1.6M$4.1M$1.5M$577.0K$3.5M$14.5M$18.6M
Other Income/Expense
$-1.6M$-4.1M$-43.0M$3.9M$12.1M$-24.4M$-18.6M
Other Special Charges
$1.9M--$48.7M--------
PRE-TAX INCOME
EBIT
$-37.2M$-50.3M$-28.1M$-102.4M$-113.4M$-88.6M$-225.1M
Pre-Tax Income
$-35.6M$-51.4M$-28.1M$-105.5M$-116.7M$-88.6M$-225.1M
INCOME TAX
Tax Provision
----$103.0K--$2.5M$18.2M$2.4M
NET INCOME
Net Income
$-35.3M$-55.7M$-32.1M$-105.5M$-119.2M$-106.8M$-227.5M
Net Income (Continuing Operations)
$-35.3M$-55.7M$-32.1M$-105.5M$-119.2M$-106.8M$-227.5M
Net Income (Discontinued Operations)
$-35.3M$-55.7M$-32.1M$-105.5M$-119.2M$-106.8M$-227.5M
Net Income (Common Stockholders)
$-35.3M$-55.7M$-32.1M$-105.5M$-119.2M$-106.8M$-227.5M
Normalized Income
------------$-222.8M
TOTALS
Total Expenses
$-75.6M$98.2M$113.8M$160.4M$196.7M$243.0M$300.5M
SHARE & EPS DATA
Average Shares Outstanding
$5.8M$23.0M$32.6M$46.1M$50.7M$60.2M$76.8M
Average Shares Outstanding (Diluted)
$6.7M$23.0M$32.6M--$50.7M$60.2M$76.8M
Shares Outstanding
$22.9M$23.1M$45.9M$46.4M$60.2M$62.4M$83.8M
Basic EPS
--$-2.43$-0.99$-2.29$-2.35$-1.78$-2.96
Basic EPS (Continuing Operations)
--$-2.43$-0.99$-2.29$-2.35$-1.78$-2.96
Diluted EPS
$-6.13$-2.43$-0.99$-2.29$-2.35$-1.78$-2.96
Diluted EPS (Continuing Operations)
--------$-2.35$-1.78$-2.96
OTHER METRICS
Net Income From Other Gains Losses
$290.0K$-4.3M$-4.1M$-3.1M------
Other Gand A
$21.4M$32.6M$36.8M$56.0M$59.5M$62.6M$48.5M
Rent And Landing Fees
$21.4M$3.6K$4.7M--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2STRO$0.89+0.4%187.37K
3
4
5
6

Get Sutro Biopharma Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.